Indication
Denosumab Allergy
2 clinical trials
2 products
1 drug
Clinical trial
Attending Doctor of Shenzhen People's HospitalStatus: Withdrawn, Estimated PCD: 2023-03-20
Product
DenosumabClinical trial
Denosumab vs Alendronate in Patients With Osteoporotic Vertebral Compression Fracture After Percutaneous Vertebroplasty: A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2023-09-20
Product
AlendronateDrug
Varlilumab